Quick Summary — CARL scores higher on quality with 6.6/10 vs DRIO's 6.3/10. CARL trades at $10.17 while DRIO trades at $7.65. Both analyzed daily using SEC EDGAR data across 13 institutional models.
CARL scores higher with a 6.6/10 quality rating vs DRIO's 6.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $10.17, CARL trades +60.1% above its Bayesian DCF fair value of $4.05, while DRIO at $7.65 trades +83.3% above its estimate of $1.28. DRIO shows a wider gap between price and intrinsic value.
CARL earns a Quality of Company score of 6.6/10 compared to DRIO's 6.3/10. The scores are closely matched, indicating similar fundamental quality profiles. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
Review the value trap analysis for both CARL and DRIO to assess whether apparent undervaluation reflects genuine opportunity or hidden fundamental risk.
Both CARL and DRIO operate in Health Information Services, which has 46 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare CARL vs DRIO differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.